Related Experiment Video
Updated: Nov 7, 2025
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.4K
Therapeutic New Era for Atopic Dermatitis: Part 2. Small Molecules
Jiyoung Ahn1, Yusung Choi2, Eric Lawrence Simpson3
1Department of Dermatology, National Medical Center, Seoul, Korea.
Annals of Dermatology
|May 3, 2021
Summary
New small molecule and biologic therapies are advancing atopic dermatitis (AD) treatment. This review summarizes the efficacy and safety of novel topical and systemic AD therapies in clinical trials.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by immune dysregulation and impaired skin barrier function.
- Recent advancements in understanding AD pathogenesis have spurred innovation in therapeutic strategies.
- New treatments include small molecule drugs and biologic therapies, offering novel approaches to disease management.
Purpose of the Study:
- To review the efficacy and safety of emerging topical and systemic therapies for atopic dermatitis (AD).
- To analyze recently published data from phase 2 and 3 clinical trials of new AD treatments.
- To highlight the impact of study design elements, such as patient population and concomitant therapies, on treatment outcomes.
Main Methods:
- Systematic review of recently published clinical trial data (Phase 2 and 3) for novel atopic dermatitis therapies.
- Analysis focused on efficacy, safety, study population characteristics, primary endpoints, and allowed concomitant topical therapies.
Main Results:
- Emerging small molecule and biologic therapies demonstrate significant potential in treating atopic dermatitis.
- Topical and systemic administration routes are being explored for these novel agents.
- Careful consideration of study design elements is crucial for interpreting treatment efficacy and safety data.
Conclusions:
- Novel small molecule and biologic therapies represent a new era in atopic dermatitis treatment.
- These targeted therapies are paving the way for personalized medicine approaches in AD management.
- Continued research and clinical trials are essential to optimize the use of these innovative treatments.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.4K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.4K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.4K
01:19Clinical Applications of Epidermal Stem Cells
3.0K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.0K
01:17Drugs Used in Lower Respiratory Disorders: Overview
776
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
776
01:29Microorganisms in Medicine and Therapeutics
607
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
607
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.2K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.2K